Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Flavodoxins as Novel Therapeutic Targets against Helicobacter pylori and Other Gastric Pathogens

10 Mar 2020

Abstract excerpt

Flavodoxins are small soluble electron transfer proteins widely present in bacteria and absent in vertebrates. Flavodoxins participate in different metabolic pathways and, in some bacteria, they have been shown to be essential proteins representing promising therapeutic targets to fight bacterial infections. Using purified flavodoxin and chemical libraries, leads can be identified that block flavodoxin function...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridium difficile and Clostridium perfringens research
Share to Helicobacter pylori-related gastroenterology studies
Share to Microbial Metabolites in Food Biotechnology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32164177
DOI: 10.3390/ijms21051881

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Flavodoxins as Novel Therapeutic Targets against Helicobacter pylori and Other Gastric PathogensPMID 32164177Read ↗

Crystal structure of oxidized flavodoxin, an essential protein in Helicobacter pylori.Semantic proximity Read ↗

Targeting Helicobacter pylori for antibacterial drug discovery with novel therapeuticsSemantic proximity Read ↗

Identification of Potential Drug Targets in Helicobacter pylori Using In Silico Subtractive Proteomics Approaches and Their Possible Inhibition through Drug RepurposingSemantic proximity Read ↗

Identification of novel drug targets in HpB38, HpP12, HpG27, Hpshi470, HpSJM180 strains of Helicobacter pylori : an in silico approach for therapeutic intervention.Semantic proximity Read ↗

Selective killing of the human gastric pathogen Helicobacter pylori by mitochondrial respiratory complex I inhibitors.Semantic proximity Read ↗

In vitro anti-Helicobacter pylori activity and phenotypic screening of novel quinolone compounds.Semantic proximity Read ↗

In Silico Identification of Potential Therapeutic Targets in the Human Pathogen Helicobacter PyloriSemantic proximity Read ↗

Helicobacter pyloridefense against oxidative attackSemantic proximity Read ↗

Systems Approaches for Unveiling the Mechanism of Action of Bismuth Drugs: New Medicinal Applications beyond Helicobacter Pylori InfectionSemantic proximity Read ↗

Identification of novel drug targets for Helicobacter pylori: structure-based virtual screening of potential inhibitors against DAH7PS protein involved in the shikimate pathwaySemantic proximity Read ↗

Identification and characterization of a Helicobacter pylori hemolysin.Semantic proximity Read ↗

2-oxoglutarate:acceptor oxidoreductase-catalyzed redox cycling effectively targets coccoid forms of Helicobacter pyloriSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.